26

2024-03

Apremilast (CC-10004), CAS:608141-41-9 大包装

Name:Apremilast (CC-10004)Formulation:in 10mM DMSOTarget:TNF-alpha,PDEPathway:MetabolismInformation:Apremilast (CC-10004) is

26

2024-03

Cobimetinib (GDC-0973, RG7420), CAS:934660-93-2 大包装

Name:Cobimetinib (GDC-0973, RG7420)Formulation:in 10mM DMSOTarget:MEKPathway:MAPKInformation:Cobimetinib (GDC-0973, RG7420) i

26

2024-03

Venetoclax (ABT-199, GDC-0199), CAS:1257044-40-8 大包装

Name:Venetoclax (ABT-199, GDC-0199)Formulation:in 10mM DMSOTarget:Bcl-2Pathway:ApoptosisInformation:Venetoclax (ABT-199, GDC-

26

2024-03

Macitentan, CAS:441798-33-0 大包装

Name:MacitentanFormulation:in 10mM DMSOTarget:Endothelin ReceptorPathway:GPCR & G ProteinInformation:Macitentan is an orally

26

2024-03

Vorapaxar, CAS:618385-01-6 大包装

Name:VorapaxarFormulation:in 10mM DMSOTarget:Protease-activated ReceptorPathway:GPCR & G ProteinInformation:Vorapaxar (SCH 53

26

2024-03

CB-5083, CAS:1542705-92-9 大包装

Name:CB-5083Formulation:in 10mM DMSOTarget:ATPasePathway:Transmembrane TransportersInformation:CB-5083 is a potent, selective

26

2024-03

Acalabrutinib (ACP-196), CAS:1420477-60-6 大包装

Name:Acalabrutinib (ACP-196)Formulation:in 10mM DMSOTarget:BTKPathway:AngiogenesisInformation:Acalabrutinib(ACP-196) is a sel

26

2024-03

Resiquimod, CAS:144875-48-9 大包装

Name:ResiquimodFormulation:in 10mM DMSOTarget:TLRPathway:Immunology & InflammationInformation:Resiquimod is an immune respons

26

2024-03

Radotinib, CAS:926037-48-1 大包装

Name:RadotinibFormulation:in 10mM DMSOTarget:Bcr-AblPathway:AngiogenesisInformation:Radotinib is a selective BCR-ABL1 tyrosin

26

2024-03

Riociguat (BAY 63-2521), CAS:625115-55-1 大包装

Name:Riociguat (BAY 63-2521)Formulation:in 10mM DMSOTarget:OthersPathway:OthersInformation:Riociguat (BAY 63-2521) is an oral

点击这里给我发消息

微信客服

微信联系

联系电话 : 18066853083

邮箱 : 2265195031@qq.com

地址 : 陕西省西安市莲湖区永新路18号天赐苑6幢10302-B80号

齐岳微信公众号

齐岳微信公众号

齐岳官方微信

齐岳官方微信

ALL Rights Reserved. 西安齐岳生物科技有限公司版权所有. 陕ICP备20008861号-4